Current approaches to the diagnosis and treatment of cholangiocarcinoma
- PMID: 16510032
- DOI: 10.1007/s11894-006-0061-1
Current approaches to the diagnosis and treatment of cholangiocarcinoma
Abstract
Malignancies arising from biliary tract epithelia, or cholangiocarcinoma, are rare tumors that have a poor prognosis. The incidence of these tumors is gradually increasing in many countries. Recent advances have been made in identifying some of the risk factors, and the need for appropriate classification is emerging. The diagnosis of cholangiocarcinoma is often difficult and requires multiple complementary studies. The use of molecular approaches may improve the diagnostic utility of biliary cytology. Treatment of these tumors is complex, and there are many different treatment options. Although surgical resection can be curative, many patients with cholangiocarcinoma are diagnosed at an advanced stage when only palliative approaches can be used. Photodynamic therapy is emerging as a useful modality.
Similar articles
-
Advances in the diagnosis, evaluation and management of cholangiocarcinoma.Curr Opin Gastroenterol. 2006 May;22(3):294-9. doi: 10.1097/01.mog.0000218967.60633.64. Curr Opin Gastroenterol. 2006. PMID: 16550045 Review.
-
Evaluation and management of intrahepatic and extrahepatic cholangiocarcinoma.Cancer. 2016 May 1;122(9):1349-69. doi: 10.1002/cncr.29692. Epub 2016 Jan 22. Cancer. 2016. PMID: 26799932 Review.
-
Cholangiocarcinoma.Nat Clin Pract Gastroenterol Hepatol. 2006 Jan;3(1):33-42. doi: 10.1038/ncpgasthep0389. Nat Clin Pract Gastroenterol Hepatol. 2006. PMID: 16397610 Review.
-
Cholangiocarcinoma.Clin Liver Dis. 2001 Feb;5(1):191-218. doi: 10.1016/s1089-3261(05)70161-6. Clin Liver Dis. 2001. PMID: 11218916 Review.
-
[Diagnostics and treatment of cholangiocarcinoma].Ned Tijdschr Geneeskd. 2008 May 3;152(18):1037-41. Ned Tijdschr Geneeskd. 2008. PMID: 18547024 Review. Dutch.
Cited by
-
Serum and tissue markers in hepatocellular carcinoma and cholangiocarcinoma: clinical and prognostic implications.Oncotarget. 2017 Feb 21;8(8):14192-14220. doi: 10.18632/oncotarget.13929. Oncotarget. 2017. PMID: 28077782 Free PMC article. Review.
-
Correlation of p53 gene mutation and expression of P53 protein in cholangiocarcinoma.World J Gastroenterol. 2006 Aug 7;12(29):4706-9. doi: 10.3748/wjg.v12.i29.4706. World J Gastroenterol. 2006. PMID: 16937443 Free PMC article.
-
Elevated CA 19-9 portends poor prognosis in patients undergoing resection of biliary malignancies.HPB (Oxford). 2010 Mar;12(2):134-8. doi: 10.1111/j.1477-2574.2009.00149.x. HPB (Oxford). 2010. PMID: 20495658 Free PMC article.
-
The value of molecular biomarkers in biliary tract cancer in the era of targeted therapy.J Clin Exp Hepatol. 2011 Jun;1(1):2-5. doi: 10.1016/S0973-6883(11)60118-7. Epub 2011 Aug 26. J Clin Exp Hepatol. 2011. PMID: 25755304 Free PMC article. No abstract available.
-
The risk factors and diagnosis of cholangiocarcinoma.Hepatol Int. 2013 Jun;7(2):377-93. doi: 10.1007/s12072-012-9407-y. Epub 2012 Nov 10. Hepatol Int. 2013. PMID: 26201772
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical